Peter O'Gorman, Jacob Laubach, Ruth Clifford, Clifton Mo, Senthil Kumar, Omar Nadeem, Monique Hartley-Brown, Siobhan Glavey, Shonali Midha, Yuxin Liu, Maja Vase, Keith Pratz, Patrick Hayden, Jessica Liegel, Paul Dowling, Emily Benjamin, Vicky Donachie, Zahra Beers, Olivia McLoughlin, Layla Horwitz, Jacinta Marron, Emma Sueiro, Marc Nolan, David Poretsky, Anna Shevlin, Sarah Beaton, Charlotte Prior, Catherine Piper, Bindu Krishnanivas, Emily Simpson, Elizabeth Karimi, Marissa Davis, Lourdes McAlester, Alanna Allen, Paul Richardson. "Isatuximab (Isa) plus lenalidomide (R), Bortezomib (V), and dexamethasone (d) (Isa-RVd) as induction therapy in transplant-eligible patients (pts) with newly diagnosed multiple myeloma (NDMM): Primary analysis of parallel phase 2 studies by the Dana-Farber Cancer Institute (DFCI) and Cancer Trials Ireland (CTI)." Blood, 2025. doi:10.1182/blood-2025-4030